News from boston scientific corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Feb 12, 2021, 09:30 ET Boston Scientific Announces February and March 2021 Conference Schedule

Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor conferences. On February 25, 2021, Dan Brennan, executive vice...

Feb 03, 2021, 06:30 ET Boston Scientific Announces Results For Fourth Quarter And Full Year 2020

Boston Scientific Corporation (NYSE: BSX) generated net sales of $2.708 billion during the fourth quarter of 2020. This represents a decline of (6.8) ...

Jan 22, 2021, 07:00 ET Boston Scientific Receives FDA Approval For The Vercise Genus™ Deep Brain Stimulation System

Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval of its fourth-generation Vercise Genus™ Deep...
Boston Scientific Launches WaveWriter Alpha™ Spinal Cord Stimulator Systems In U.S.

Jan 14, 2021, 07:00 ET Boston Scientific Launches WaveWriter Alpha™ Spinal Cord Stimulator Systems In U.S.

Boston Scientific (NYSE: BSX) has announced a limited market release of the WaveWriter Alpha™ portfolio of Spinal Cord Stimulator (SCS) systems. The...

Jan 12, 2021, 06:30 ET Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year 2020

Boston Scientific Corporation (NYSE: BSX) generated net sales, based upon preliminary unaudited financial information, of approximately $2.71 billion ...

Jan 04, 2021, 09:30 ET Boston Scientific to Participate in J.P. Morgan Healthcare Conference and Announces Conference Call Discussing Fourth Quarter 2020 Results

Boston Scientific Corporation (NYSE: BSX) will participate in the virtually held 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January...

Dec 14, 2020, 18:54 ET Boston Scientific Announces Stipulation Of Dismissal Of Nevro Corporation's Patent Infringement Case In California

Boston Scientific Corporation (NYSE: BSX) today announced that a stipulation of dismissal has been filed in the Nevro Corporation (NYSE: NVRO) patent ...

Dec 01, 2020, 06:30 ET Boston Scientific Signs Definitive Agreement to Divest BTG Specialty Pharmaceuticals Business

Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a definitive agreement with Stark International Lux S.A.R.L., and...

Nov 23, 2020, 09:30 ET Boston Scientific to Participate in Evercore ISI 2020 Healthcare Conference

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2020 Evercore ISI HealthCONx Conference on December 1. Mike Mahoney,...

Nov 17, 2020, 06:00 ET Boston Scientific Announces LOTUS Edge™ Aortic Valve System Voluntary Recall and Product Discontinuation

Boston Scientific Corporation (NYSE: BSX) has announced it has initiated a global, voluntary recall of all unused inventory of the LOTUS Edge™ Aortic ...

Nov 05, 2020, 09:30 ET Boston Scientific Announces November 2020 Conference Schedule

Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming virtual investor conferences. On November 12, 2020, Meghan Scanlon, senior ...

Nov 02, 2020, 09:41 ET Boston Scientific Receives FDA Approval for the Ranger™ Drug-Coated Balloon

Boston Scientific (NYSE: BSX) announced it has received U.S. Food and Drug Administration (FDA) approval of the Ranger™ Drug-Coated Balloon,...

Oct 29, 2020, 06:55 ET Boston Scientific Initiates Trial to Evaluate WATCHMAN FLX™ Left Atrial Appendage Closure Device as First-Line Treatment for People at Risk of Stroke

Boston Scientific Corporation (NYSE: BSX) has initiated the CHAMPION-AF clinical trial to evaluate the safety and efficacy of the WATCHMAN FLX™ Left...

Oct 28, 2020, 06:30 ET Boston Scientific Announces Results For Third Quarter 2020

Boston Scientific Corporation (NYSE: BSX) generated sales of $2.659 billion during the third quarter of 2020. This represents a decline of (1.8)...

Oct 01, 2020, 09:30 ET Boston Scientific Announces Transcatheter Cardiovascular Therapeutics 2020 Investor Update and Conference Call Discussing Third Quarter 2020 Results

Boston Scientific Corporation (NYSE: BSX) will webcast an investor update at the virtual 2020 Transcatheter Cardiovascular Therapeutics (TCT) on...

Sep 30, 2020, 16:01 ET Boston Scientific Launches WaveWriter Alpha™ Spinal Cord Stimulator Systems In Europe

Boston Scientific (NYSE: BSX) today announced the European launch of the WaveWriter Alpha™ portfolio of Spinal Cord Stimulator (SCS) Systems. The...

Sep 28, 2020, 06:45 ET Boston Scientific Launches ACURATE neo2™ Aortic Valve System in Europe

Boston Scientific Corporation (NYSE: BSX) today announced it has initiated a controlled launch of the ACURATE neo2™ Aortic Valve System in Europe....

Sep 21, 2020, 07:00 ET Boston Scientific Announces Expanded Investment and Exclusive Acquisition Option Agreement with Farapulse, Inc.

Boston Scientific Corporation (NYSE: BSX) today announced it has signed an investment agreement with an exclusive option to acquire Farapulse, Inc.,...

Sep 09, 2020, 18:38 ET Boston Scientific Launches Vercise Genus™ DBS System In Europe

Boston Scientific Corporation (NYSE: BSX) announced it has received CE Mark and initiated a limited market release of the fourth generation Vercise...

Sep 03, 2020, 07:00 ET CMS Grants Additional Reimbursement For The Eluvia™ Drug-Eluting Vascular Stent System

Boston Scientific (NYSE: BSX) announced that the U.S. Centers for Medicare and Medicaid Services (CMS) granted a New Technology Add-on Payment (NTAP) ...

Aug 26, 2020, 09:30 ET Boston Scientific Announces September 2020 Conference Schedule

Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming virtual investor conferences. On September 9, 2020, Mike Mahoney, chairman ...

Jul 29, 2020, 06:30 ET Boston Scientific Announces Results For Second Quarter 2020

Boston Scientific Corporation (NYSE: BSX) generated sales of $2.003 billion during the second quarter of 2020. This represents a decline of (23.9)...

Jul 21, 2020, 16:24 ET Boston Scientific Receives FDA Approval for Next-Generation WATCHMAN FLX™ Left Atrial Appendage Closure Device

Boston Scientific Corporation (NYSE: BSX) announced it has received U.S. Food and Drug Administration (FDA) approval for the WATCHMAN FLX™ Left...

Jun 30, 2020, 09:30 ET Boston Scientific Announces Conference Call Discussing Second Quarter 2020 Financial Results

Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the second...

Jun 29, 2020, 06:55 ET Boston Scientific Receives FDA 510(k) Clearance for the LUX-Dx™ Insertable Cardiac Monitor System

Boston Scientific (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the LUX-Dx™ Insertable Cardiac Monitor (ICM)...